Company Overview and News
Duke Energy’s (DUK - Free Report) subsidiary — Duke Energy Carolinas — applied for new rates to the North Carolina Utilities Commission (“NCUC”). The company will pass the savings from recent federal tax reform to all customers groups. The new electric rates will be phased out over the next four years and will decline by average 1.34% post NCUC’s approval and adjust to a 0.22% fall in August 2022 However, residential customers will experience a marginal increase in utility bills.
WFCNP SOJA WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN AGR WFC.PRY WFC.PRX WFC.PRW NEE WFC.PRV WFC WFC.WS SO DUKH UNP DUK NEE.PRI NEE.PRJ NEE.PRC NEE.PRQ NEE.PRR
Duke Energy Corporation (DUK - Free Report) announced that its subsidiary — Duke Energy Renewables — has finalized the acquisition of the Shoreham Solar Commons project from Invenergy. Located in Brookhaven, NY, the facility is one of the largest solar projects in New York and has a capacity to generate 24.9 megawatts (MW) of solar power.
NRGEO NRG DUKH AEE AGR DUK
Atlantica Yield’s (AY - Free Report) earnings estimates have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings has moved 26.1% and 22.4% north to 87 cents and $1.04 per share, respectively, within the same time frame. Atlantica Yield, a Zacks Rank #1 (Strong Buy) stock, owns, acquires and operates renewable energy, natural gas, power, electric transmission lines, and water assets in North America, South America, Spain, Algeria, and South Africa.
NI AY AGR AQN
Earnings estimates for Atmos Energy Corporation (ATO - Free Report) have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2018 earnings has moved 0.5% north to $3.99 per share. Atmos Energy, along with subsidiaries, is engaged in regulated natural gas distribution and storage business. The company serves in excess of three million natural gas distribution customers across more than 1,400 communities in eight states from the Blue Ridge Mountains in the East to the Rocky Mountains in the West.
NI AEE AGR ATO
Duke Energy Corporation (DUK - Free Report) recently announced that the board of directors approved a quarterly cash dividend of 93 cents per share on its common stock. This would mark a quarterly increase of 3.75 cents or 4.2%. Per the company, the dividend will be payable on Sep 17, 2018 to stockholders on record as of Aug 17. The estimated annual yield on the dividend is 4.3%. Regular Distribution Hikes Duke Energy has been raising its cash dividend per share every year and this is the 92nd consecutive year, in which the company has continued with the same trend.
NRGEO NRG DUKH AEE AGR CVRR DUK
Earnings estimates for CMS Energy Corporation (CMS - Free Report) have been revised upward in the past 30 days. The Zacks Consensus Estimate for 2019 has inched up 0.4% to $2.51. Estimates for 2018 remain unchanged at $2.33. CMS Energy’s earnings have surpassed the Zacks Consensus Estimate in three out of the trailing four quarters. In a year's time, the stock has returned 4.9% against its industry’s decline of 0.
AEE CMSA OTTR AGR CMS
Duke Energy (NYSE:DUK) will pass on an amount of $142 million in annual tax savings to the electric bills of its Indiana-based customers, if the proposed settlement with consumer groups is approved by Indiana Utility Regulatory Commission.
NEE.PRI DUKH NEE.PRJ NEE.PRC WGL NEE.PRQ AGR NEE.PRR DUK NEE
Duke Energy Corp. (DUK - Free Report) will pass on an amount of $142 million in annual tax savings to the electric bills of its Indiana-based customers, if the proposed settlement with consumer groups is approved by Indiana Utility Regulatory Commission. The Tax Cuts and Jobs Act — amended in late 2017 — came into effect on Jan 1, 2018 and has clearly led to this entire bill reduction. Details of Tax Savings The company’s customers, particularly residing in Indiana, would save approximately $142 million in annual tax on their electric bills.
NEE.PRI DUKH NEE.PRJ NEE.PRC WGL NEE.PRQ AGR NEE.PRR DUK NEE
Edison International’s (EIX - Free Report) unit, Southern California Edison (“SCE”), appealed to the California Public Utilities Commission ("CPUC") for the expansion of Charge Ready 2. It is a program that will expand the installation of electric vehicle (“EV”) charging infrastructure in California. This $760-million, four-year program will allow the company to install 48,000 charging ports. Recently, SCE installed the 1000th EV charging point to increase the availability of in transportation.
EIX AEE SCEDN SCE.PRD SCEDP SCE.PRE SCE.PRB SCE.PRF SCE.PRC OTTR AGR SCE
OGE Energy Corp’s. (OGE - Free Report) subsidiary, Oklahoma Gas & Electric Company (OG&E), recently signed an agreement with Oklahoma Corporation Commission (OCC) and other regulatory parties to review rates for its Oklahoma customers. If approved, the new rates will take effect from Jul 1, 2018. Alongside the agreement, the company also reaffirmed its 2018 earnings guidance. It continues to expect the net income in the range of $380-$410 million or $1.
NEE.PRI DUKH NEE.PRJ SPG.PRJ NEE.PRC NEE.PRQ AGR NEE.PRR DUK SPG NEE OGE
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to AGR / Avangrid, Inc. on message board site Silicon Investor.
as of ET